Simplex Trading’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-771
| Closed | -$9K | – | 10382 |
|
|
2023
Q1 | $9K | Sell |
771
-485
| -39% | -$8.06K | ﹤0.01% | 7681 |
|
|
2022
Q4 | $19K | Buy |
1,256
+911
| +264% | +$10.6K | ﹤0.01% | 6956 |
|
|
2022
Q3 | $2K | Sell |
345
-49
| -12% | -$410 | ﹤0.01% | 9448 |
|
|
2022
Q2 | $3K | Buy |
394
+109
| +38% | +$1.94K | ﹤0.01% | 9253 |
|
|
2022
Q1 | $9K | Sell |
285
-185
| -39% | -$7.28K | ﹤0.01% | 9010 |
|
|
2021
Q4 | $22K | Buy |
+470
| New | +$32.4K | ﹤0.01% | 8282 |
|
|
2021
Q2 | – | Sell |
-277
| Closed | -$24.2K | – | 10924 |
|
|
2021
Q1 | $26K | Buy |
+277
| New | +$34K | ﹤0.01% | 7257 |
|
|
2020
Q2 | – | Sell |
-227
| Closed | -$24K | – | 8612 |
|
|
2020
Q1 | $25K | Buy |
227
+42
| +23% | +$8.27K | ﹤0.01% | 5786 |
|
|
2019
Q4 | $45K | Buy |
+185
| New | +$46.7K | ﹤0.01% | 5302 |
|
|
2019
Q3 | – | Sell |
-21
| Closed | -$11.4K | – | 8086 |
|
|
2019
Q2 | $18K | Sell |
21
-60
| -74% | -$73.7K | ﹤0.01% | 5710 |
|
|
2019
Q1 | $129K | Buy |
+81
| New | +$146K | ﹤0.01% | 4079 |
|
|
2018
Q3 | – | Sell |
-256
| Closed | -$792K | – | 8278 |
|
|
2018
Q2 | $882K | Buy |
256
+154
| +151% | +$472K | ﹤0.01% | 1917 |
|
|
2018
Q1 | $288K | Buy |
102
+85
| +500% | +$255K | 0.01% | 1006 |
|
|
2017
Q4 | $43K | Sell |
17
-98
| -85% | -$279K | ﹤0.01% | 2605 |
|
|
2017
Q3 | $325K | Sell |
115
-9
| -7% | -$23.7K | 0.01% | 912 |
|
|
2017
Q2 | $292K | Buy |
124
+106
| +589% | +$210K | 0.01% | 964 |
|
|
2017
Q1 | $46K | Sell |
18
-439
| -96% | -$1.26M | ﹤0.01% | 2457 |
|
|
2016
Q4 | $1.03M | Buy |
457
+388
| +562% | +$922K | 0.06% | 275 |
|
|
2016
Q3 | $172K | Sell |
69
-33
| -32% | -$98.5K | 0.01% | 1136 |
|
|
2016
Q2 | $312K | Buy |
102
+62
| +155% | +$202K | 0.02% | 752 |
|
|
2016
Q1 | $127K | Buy |
40
+38
| +1,900% | +$158K | 0.01% | 1172 |
|
|
2015
Q4 | $9K | Sell |
2
-17
| -89% | -$74.3K | ﹤0.01% | 3437 |
|
|
2015
Q3 | $59K | Buy |
19
+9
| +90% | +$34.9K | ﹤0.01% | 1849 |
|
|
2015
Q2 | $38K | Sell |
10
-13
| -57% | -$50.2K | ﹤0.01% | 1918 |
|
|
2015
Q1 | $92K | Buy |
23
+1
| +5% | +$4.58K | 0.01% | 1153 |
|
|
2014
Q4 | $107K | Buy |
+22
| New | +$94.4K | 0.01% | 903 |
|
Other funds holding ACOR
DKCM
Simplex Trading's ACOR Position: Q2 2023 in Review
Simplex Trading sold out of Acorda Therapeutics (ACOR) in Q2 2023, closing a stake of 771 shares — an estimated $9K sold.
Simplex Trading first reported a position in ACOR in Q4 2014 and held it in 26 quarters. The position peaked at $1.03M in Q4 2016. 15 funds tracked by Wall St. Rank hold ACOR as of Q2 2023.
- Simplex Trading reported no remaining Acorda Therapeutics position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 771 Acorda Therapeutics shares in Q2 2023, an estimated $9K.
- Simplex Trading first reported a position in Acorda Therapeutics in Q4 2014 and held it in 26 quarters.
- Simplex Trading's Acorda Therapeutics position peaked at $1.03M in Q4 2016.
- 15 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.